2019

• Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma. Loriot Y, Necchi A, Park SH, Garcia-Donas J, Huddart R, Burgess E, Fleming M, Rezazadeh A, Mellado B, Varlamov S, Joshi M, Duran I, Tagawa ST, Zakharia Y, Zhong B, Stuyckens K, Santiago-Walker A, De Porre P, O'Hagan A, Avadhani A, Jinga V, Siefker-Radtke AO; BLC2001 Study Group. N Engl J Med. 2019 Jul 25;381(4):338-348. doi: 10.1056/NEJMoa1817323.
• Sex specific associations in genome wide association analysis of renal cell carcinoma. Laskar RS, Muller DC, Li P, Machiela MJ, Ye Y, Gaborieau V, Foll M, Hofmann JN, Colli L, Sampson JN, Wang Z, Bacq-Daian D, Boland A, Abedi-Ardekani B, Durand G, Le Calvez-Kelm F, Robinot N, Blanche H, Prokhortchouk E, Skryabin KG, Burdett L, Yeager M, Radojevic-Skodric S, Savic S, Foretova L, Holcatova I, Janout V, Mates D, Rascu S, Mukeria A, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Świątkowska B, Benhamou S, Cancel-Tassin G, Cussenot O, Trichopoulou A, Riboli E, Overvad K, Panico S, Ljungberg B, Sitaram RT, Giles GG, Milne RL, Severi G, Bruinsma F, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Beane Freeman LE, Koutros S, Albanes D, Männistö S, Weinstein S, Clark PE, Edwards TL, Lipworth L, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Michael Gaziano J, Sesso HD, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Teh BT, Peters U, White E, Anderson GL, Johnson L, Luo J, Chow WH, Moore LE, Choueiri TK, Wood C, Johansson M, McKay JD, Brown KM, Rothman N, Lathrop MG, Deleuze JF, Wu X, Brennan P, Chanock SJ, Purdue MP, Scelo G. Eur J Hum Genet. 2019 Jun 23. doi: 10.1038/s41431-019-0455-9. (Factor de impact: 3,65). PMID: 31231134
• Genetic Risk Score for Prostate Cancer in the Romanian Population. RAZVAN DANAU, DUMITRU CRISTINEL BADIU, PAUL IORDACHE, RADU URSU, VIORICA RADOI, STEFAN RASCU, GEORGE DANIEL RADAVOI, CRISTIAN SORIN SIMA, CRISTIAN TOMA, BOGDAN BRATICEVICI, MIHAELA MANDU, TITUS VALENTIN GRIGOREAN, VIOREL JINGA. Rom Biotechnol Lett. 2019; 24(1): 100-107. doi: 10.25083/rbl/24.1/100.107
• The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study. Johansson M, Carreras-Torres R, Scelo G, Purdue MP, Mariosa D, Muller DC, Timpson NJ, Haycock PC, Brown KM, Wang Z, Ye Y, Hofmann JN, Foll M, Gaborieau V, Machiela MJ, Colli LM, Li P, Garnier JG, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Radojevic-Skodric S, Ognjanovic S, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Benhamou S, Cancel-Tassin G, Cussenot O, Weiderpass E, Ljungberg B, Tumkur Sitaram R, Häggström C, Bruinsma F, Jordan SJ, Severi G, Winship I, Hveem K, Vatten LJ, Fletcher T, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Andreotti G, Beane Freeman LE, Koutros S, Männistö S, Weinstein S, Clark PE, Edwards TL, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Wilson KM, Gaziano JM, Sesso HD, Freedman ND, Parker AS, Eckel-Passow JE, Huang WY, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Teh BT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Eisen T, Henrion M, Larkin J, Barman P, Leibovich BC, Choueiri TK, Lathrop GM, Deleuze JF, Gunter M, McKay JD, Wu X, Houlston RS, Chanock SJ, Relton C, Richards JB, Martin RM, Davey Smith G, Brennan P. PLoS Med. 2019 Jan 3;16(1):e1002724. doi: 10.1371/journal.pmed.1002724. eCollection 2019 Jan
• Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer. Chi KN, Agarwal N, Bjartell A, Chung BH, Pereira de Santana Gomes AJ, Given R, Juárez Soto Á, Merseburger AS, Özgüroğlu M, Uemura H, Ye D, Deprince K, Naini V, Li J, Cheng S, Yu MK, Zhang K, Larsen JS, Jinga V, McCarthy S, Chowdhury S; TITAN Investigators. N Engl J Med. 2019 Jul 4;381(1):13-24. doi: 10.1056/NEJMoa1903307. Epub 2019 May 31
• OBESITY: A DELICATE ISSUE CHOOSING THE ESWL TREATMENT FOR PATIENTS WITH KIDNEY AND URETERAL STONES? Pricop C, Radavoi GD, Puia D, Vechiu C, Jinga V. Acta Endocrinol (Buchar). 2019 Jan-Mar;-5(1):133-138. doi: 10.4183/aeb.2019.133.
• Once-Daily Plazomicin for Complicated Urinary Tract Infections. Wagenlehner FME, Cloutier DJ, Komirenko AS, Cebrik DS, Krause KM, Keepers TR, Connolly LE, Miller LG, Friedland I, Jinga V, Dwyer JP; EPIC Study Group. N Engl J Med. 2019 Feb 21;380(8):729-740. doi: 10.1056/NEJMoa1801467
• Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer. Fizazi K, Shore N, Tammela TL, Ulys A, Vjaters E, Polyakov S, Jievaltas M, Luz M, Alekseev B, Kuss I, Kappeler C, Snapir A, Sarapohja T, Jinga V, Smith MR; ARAMIS Investigators. N Engl J Med. 2019 Mar 28;380(13):1235-1246. doi: 10.1056/NEJMoa1815671. Epub 2019 Feb 14

2018

• Occupational exposure to urinary bladder carcinogens - risk factors, molecular mechanisms and biomarkers. Marina Ruxandra Otelea, Viorel Jinga, Alexandru Stefan Catalin Rascu, Iancu Emil Plesea, Amelia Nicoleta Petrescu, Luminita Elena Mitrache, Mihai Olteanu, Dan Bondari, Agripina Rascu. Rom J Morphol Embryol 2018, 59(4)
• Phytochemical Profile and Biological Activities of Satureja hortensis L.: A Review of the Last Decade. Fierascu I, Dinu-Pirvu CE, Fierascu RC, Velescu BS, Anuta V, Ortan A, Jinga V. Molecules. 2018 Sep 25;23(10). pii: E2458. doi: 10.3390/molecules23102458. FACTOR IMPACT – 3,09
• Identification of Lynch syndrome risk variants in the Romanian population. Iordache PD, Mates D, Gunnarsson B, Eggertsson HP, Sulem P, Benonisdottir S, Csiki IE, Rascu S, Radavoi D, Ursu R, Staicu C, Calota V, Voinoiu A, Jinga M, Rosoga G, Danau R, Sima SC, Badescu D, Suciu N, Radoi V, Mates IN, Dobra M, Nicolae C, Kristjansdottir S, Jonasson JG, Manolescu A, Arnadottir G, Jensson B, Jonasdottir A, Sigurdsson A, le Roux L, Johannsdottir H, Rafnar T, Halldorsson BV, Jinga V, Stefansson K. J Cell Mol Med. 2018 Dec;22(12):6068-6076. doi: 10.1111/jcmm.13881. Epub 2018 Oct 16
• Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss. de Bono JS, De Giorgi U, Rodrigues DN, Massard C, Bracarda S, Font A, Arranz Arija JA, Shih KC, Radavoi GD, Xu N, Chan WY, Ma H, Gendreau S, Riisnaes R, Patel PH, Maslyar DJ, Jinga V. Clin Cancer Res. 2018 Jul 23. doi: 10.1158/1078-0432.CCR-18-0981.
• Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer. Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer. Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Jinga V, Small EJ. N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8
• Profile of common prostate cancer risk variants in an unscreened Romanian population. Iordache PD, Mates D, Gunnarsson B, Eggertsson HP, Sulem P, Guðmundsson J, Benónísdóttir S, Csiki IE, Rascu S, Radavoi D, Ursu R, Staicu C, Calota V, Voinoiu A, Jinga M, Rosoga G, Danau R, Sima SC, Badescu D, Suciu N, Radoi V, Manolescu A, Rafnar T, Halldórsson BV, Jinga V, Stefánsson K. J Cell Mol Med. 2018 Mar;22(3):1574-1582. doi: 10.1111/jcmm.13433. Epub 2017 Dec 20.
• Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma. Machiela MJ, Hofmann JN, Carreras-Torres R, Brown KM, Johansson M, Wang Z, Foll M, Li P, Rothman N, Savage SA, Gaborieau V, McKay JD, Ye Y, Henrion M, Bruinsma F, Jordan S, Severi G, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Mannisto S, Weinstein S, Clark PE, Edwards TE, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Gaziano JM, Sesso HS, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Colli LM, Sampson JN, Besse C, Blanche H, Boland A, Burdette L, Prokhortchouk E, Skryabin KG, Yeager M, Mijuskovic M, Ognjanovic M, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Bueno-de-Mesquita HB, Canzian F, Duell EJ, Ljungberg B, Sitaram RT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Larkin J, Choueiri TK, Lathrop GM, Teh BT, Deleuze JF, Wu X, Houlston RS, Brennan P, Chanock SJ, Scelo G, Purdue MP. Eur Urol. 2017 Nov;72(5):747-754. doi: 10.1016/j.eururo.2017.07.015. Epub 2017 Aug 7. Erratum in: Eur Urol. 2018 May 28;:. PMID: 28797570

2017

• Genome-wide association study identifies multiple risk loci for renal cell carcinoma. Scelo G, Purdue MP, Brown KM, Johansson M, Wang Z, Eckel-Passow JE, Ye Y, Hofmann JN, Choi J, Foll M, Gaborieau V, Machiela MJ, Colli LM, Li P, Sampson JN, Abedi-Ardekani B, Besse C, Blanche H, Boland A, Burdette L, Chabrier A, Durand G, Le Calvez-Kelm F, Prokhortchouk E, Robinot N, Skryabin KG, Wozniak MB, Yeager M, Basta-Jovanovic G, Dzamic Z, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Baglietto L, Boeing H, Khaw KT, Weiderpass E, Ljungberg B, Sitaram RT, Bruinsma F, Jordan SJ, Severi G, Winship I, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Männistö S, Weinstein S, Clark PE, Edwards TL, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Michael Gaziano J, Sesso HD, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Teh BT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, Chow WH, Moore LE, Wood C, Eisen T, Henrion M, Larkin J, Barman P, Leibovich BC, Choueiri TK, Mark Lathrop G, Rothman N, Deleuze JF, McKay JD, Parker AS, Wu X, Houlston RS, Brennan P, Chanock SJ. Nat Commun. 2017 Jun 9;8:15724. doi: 10.1038/ncomms15724
• Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer. Fizazi K, Tran N, Fein L, Matsubara N, Rodriguez-Antolin A, Alekseev BY, Özgüroğlu M, Ye D, Feyerabend S1, Protheroe A, De Porre P, Kheoh T, Park YC, Todd MB, Chi KN, Korbenfeld E, Metrebian S, Kaen L, Staneloni E, Batagelj E, Tan H, Hovey E, Woo H, Frydenberg M, Chua W, D’Hondt L, Evaraert E, Verschaeve V, Wynendaele W, Schrijvers D, Waltregny D, Whenham N, Demey W, Franke F, Panhoca R, Damião R, Zucca L, Da Rosa V, Reis R, Scalabrini A, Nahas W, Girotto G, Nogueira A, Gomes A, Coradazzi A, Kurteva G, Siemens R, Gingerich J, Fleshner N, Fradet Y, Morgan S, North S, Saad F, Shayegan B, Zalewski P, Pinochet R, Orellana N, Ding Q, Ye Z, Xie L, Du C, Chen Z, Huang Y, Sun Z, Li H, Jin J, Li C, Wan B, Tian Y, Zhou F, Xie K, Yao X, Qiu M, Zou Q, Na Y, Sun Y, Xue B, Ma L, Martinez C, Salazar M, Larios C, Solano S, Pavlik I, Brodak M, Hora M, Büchler T, Borre M, Johansen J, Mejlholm I, Poulsen M, Wittendorf HE, Tammela T, Vaarala M, Theodore C, Staudacher L, Villers A, Laplaige P, Suttman H, Steuber T, Natale S, Jones R, Tran A, Mazhar D, Mills J, Nyirady P, Salamon C, Torzsok F, Feher J, Géczi L, Lakatos A, Keizman D, Sella A, Frank S, Peer A, Rosenbaum E, Berger R, Mermershtain W, Carteni G, Tonini G, De Giorgi U, Facchini G, Berruti A, Bracarda S, Basso U, Galli L, Tortora G, Alietta M, Fukasawa S, Suzuki H, Hasumi H, Tsuchiya T, Uemura H, Kanayama H, Hashine K, Sato F, Matsumoto H, Oya M, Lee JL, Park S, Keam B, Yun H, Kim Y, Kang B, Lee K, Kim C, Saad M, Sundram M, Calvo D, Moreno R, Rodriquez J, Hernandez C, van den Berg H, De La Rosett J, Van Moorse R, Hunting J, Hendriks M, Kueppers F, Gilling P, Beaven A, Holmes M, Jassem J, Oszukowska E, Niezabitowski J, Jaxa-Larecka D, Chwalinski M, Swiniarski P, Silva C, Conceicãoa P, Fraga A, Mauricio J, Rodrigues T, Pinheiro L, Lima E, Palma Dos Reis J, Volovat C, Jinga V, Harza M, Alyasova A, Budnik N, Bychkov Y, Izmaylov A, Khvorosten D, Matveev V, Novsov A, Vladimirov V, Tevs D, Sheveleva L, Bulanov A, Semenov A, Fadeeva N, Kulikov E, Emelyanov S, Karyakin O, Shirinkin V, Shkolnik M, Lykov A, Skopin P, Kopyltsov E, Mincik I, Mir O, Kliment J, Mikurcik E, Gajdos M, Milichovsky I, Malan J, Bahlmann J, Moshokoa E, Madlala T, Coetzee L, Ribal M, Miñana B, Martinez Breijo S, Carballido J, Olmos D, Requena M, Morote J, Damber JE, Haggman M, Nyman C, Ljungberg B, Bjartell A, Ozen H, Beduk Y, Sozen S, Cetinkaya M, Ozyurt M, Tansug Z, Mungan A, Tanidir Y, Toktas M, Hotko E, Stus V, Lyulko O, Vinnyk Y, Shparyk Y, Sakalo V, Bondarenko I, Paramonov V, Khareba G, Hodos V. N Engl J Med 2017;377(4):352-360.
• Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma. Arseneault M, Monlong J, Vasudev NS, Laskar RS, Safisamghabadi M, Harnden P, Egevad L, Nourbehesht N, Panichnantakul P, Holcatova I, Brisuda A, Janout V, Kollarova H, Foretova L, Navratilova M, Mates D, Jinga V, Zaridze D, Mukeria A, Jandaghi P, Brennan P, Brazma A, Tost J, Scelo G, Banks RE, Lathrop M, Bourque G, Riazalhosseini Y. Sci Rep 2017; ;7:44876. doi: 10.1038/srep44876.

2016

• Replication study of 34 common SNPs associated with prostate cancer in the Romanian population. Viorel Jinga, Irma Eva Csiki, Andrei Manolescu, Paul Iordache, Ioan Nicolae Mates, Daniel Radavoi, Stefan Rascu, Daniel Badescu, Paula Badea, Dana Mates. Journal of Cellular and Moelcular Medicine 2016, ISSN: 1582-4934, http://onlinelibrary.wiley.com/doi/10.1111/jcmm.12729/epdf
• A comprehensive analysis of genome-wide association studies to identify prostate cancer susceptibility loci for the Romanian population. Rădăvoi GD, Pricop C, Jinga V, Mateş D, Rădoi VE, Jinga M, Ursu RI, Bratu OG, Mischianu DL, Iordache P. Rom J Morphol Embryol. 2016;57(2):467-75
• Insertion of an SVA-E retrotransposon into the CASP8 gene is associated with protection against prostate cancer. Stacey SN, Kehr B, Gudmundsson J, Zink F, Jonasdottir A, Gudjonsson SA, Sigurdsson A, Halldorsson BV, Agnarsson BA, Benediktsdottir KR, Aben KK, Vermeulen SH, Cremers RG, Panadero A, Helfand BT, Cooper PR, Donovan JL, Hamdy FC, Jinga V, Okamoto I, Jonasson JG, Tryggvadottir L, Johannsdottir H, Kristinsdottir AM, Masson G, Magnusson OT, Iordache PD, Helgason A, Helgason H, Sulem P, Gudbjartsson DF, Kong A, Jonsson E, Barkardottir RB, Einarsson GV, Rafnar T, Thorsteinsdottir U, Mates IN, Neal DE, Catalona WJ, Mayordomo JI, Kiemeney LA, Thorleifsson G, Stefansson K. Hum Mol Genet. 2016 Mar 1;25(5):1008-18. doi: 10.1093/hmg/ddv622. Epub 2016 Jan 5
• Aristolochic acid exposure in Romania and implications for renal cell carcinoma. Turesky RJ, Yun BH, Brennan P, Mates D, Jinga V, Harnden P, Banks RE, Blanche H, Bihoreau MT, Chopard P, Letourneau L, Lathrop GM, Scelo G. Br J Cancer. 2016 Jan 12;114(1):76-80. doi:10.1038/bjc.2015.402.

2015

• Efficacy of triptorelin pamoate 11.25 mg administered subcutaneously for achieving medical castration levels of testosterone in patients with locally advanced or metastatic prostate cancer. Lebret T, Rouanne M, Hublarov O, Jinga V, Petkova L, Kotsev R, Sinescu I, Dutailly P. Therapeutic Advances in Urology 2015. ISSN: 1756-2872
• Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial. Saad F, Fizazi K, Jinga V, Efstathiou E, Fong PC, Hart LL, Jones R, McDermott R, Wirth M, Suzuki K, MacLean DB, Wang L, Akaza H, Nelson J, Scher HI, Dreicer R, Webb IJ, de Wit R; ELM-PC 4 investigator. The Lancet Oncology 2015. ISSN: 1470-2045

2014

• Variation in genomic landscape of clear cell renal cell carcinoma across Europe. Scelo G, Riazalhosseini Y, Greger L, Letourneau L, Gonzàlez-Porta M, Wozniak MB, Bourgey M, Harnden P, Egevad L, Jackson SM, Karimzadeh M, Arseneault M, Lepage P, How-Kit A, Daunay A, Renault V, Blanché H, Tubacher E, Sehmoun J, Viksna J, Celms E, Opmanis M, Zarins A, Vasudev NS, Seywright M, Abedi-Ardekani B, Carreira C, Selby PJ, Cartledge JJ, Byrnes G, Zavadil J, Su J, Holcatova I, Brisuda A, Zaridze D, Moukeria A, Foretova L, Navratilova M, Mates D, Jinga V, Artemov A, Nedoluzhko A, Mazur A, Rastorguev S, Boulygina E, Heath S, Gut M, Bihoreau MT, Lechner D, Foglio M, Gut IG, Skryabin K, Prokhortchouk E, Cambon-Thomsen A, Rung J, Bourque G, Brennan P, Tost J, Banks RE, Brazma A, Lathrop GM. Nat Commun. 2014 Oct 29;5:5135. doi: 10.1038/ncomms6135 ISSN: 2041-1723
• Differences in Ureteroscopic Stone Treatment and Outcomes for Distal, Mid-, Proximal, or Multiple Ureteral Locations: The Clinical Research Office of the Endourological Society Ureteroscopy Global Study. Perez Castro E, Osther PJ, Jinga V, Razvi H, Stravodimos KG, Parikh K, Kural AR, de la Rosette JJ; on behalf of the CROES Ureteroscopy Global Study Group. Eur Urol. 2014 Jan 23. pii: S0302-2838(14)00023-2. ISSN: 0302-2838

2013

• Transarterial embolization of renal vascular lesions after percutaneous nephrolithotomy. Jinga V, Dorobat B, Youssef S, Radavoi G, Braticevici B, Filipoiu F, Balgradean M. Chirurgia (Bucur). 2013 Jul-Aug;108(4):521-9.ISSN: 1221-9118
• Gentamicin, infections, and acute tubular necrosis in children. M. Bălgrădean, E. Cinteză, F. Filipoiu, Jinga. Farmacia 2013;61:772-80.ISSN: 0014-8237
• Sudden death of a premature newborn with hypoplastic left heart syndrome. Morfological study of the heart. Filipoiu F.M., Bălgrădean M., Jinga V. Romanian Journal of Legal Medicine 2013; 21:27-30. ISSN: 1221-8618
• Anatomical description of the deep venous channel from the anterior vestibular wall of the right atrium. Filipoiu F.M., Balgradean M., Brezean I., Jinga V. Rom J Morphol Embryol. 2013;54(3). ISSN: 1220-0522
• Risk factors and complications leading to mortality from hemolytic uremic syndrome in child. Three case reports. Balgradean M., Cinteza E., Filipoiu F., Jinga V. RJLM 2013; XXI. ISSN: 1221-8618
• Ventral buccal mucosa graft urethroplasty for penile urethral strictures: a predictable failure? Jinga V, Hurduc M, Voinescu V, Filipoiu F, Balgradeanu M. Chirurgia (Bucur). 2013 Mar-Apr;108(2):245-9. ISSN: 1221-9118
• Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity. Stöhrer M, Mürtz G, Kramer G, Warnack W, Primus G, Jinga V, Manu-Marin A, Calomfirescu N, Strugala G. Spinal Cord. 2013 May;51(5):419-23. doi: 10.1038/sc.2012.174. Epub 2013 Jan 22. ISSN: 1362-4393
• Death caused by hemolytic-uremic syndrome. Case Balgradean  M., Ceausu M., Cinteza E., Filipoiu F., Hostiuc S., Jinga V., Sirbu D., Spataru R.I. RJLM 2013; XXI

2012

• A rare case of digestive hemorrhage in an elderly patient: diagnosis and treatment difficulties. Jinga M, Jurcuţ C, Vasilescu F, Becheanu G, Stancu SH, Ciobaca L, Mircescu G, Jinga V. Rom J Morphol Embryol. 2012;53(3 Suppl):831-4. ISSN: 1220-0522
• Penile abscess and urethrocutaneous fistula following intracavernous injection: a case report. Jinga V, Iconaru V. J Sex Med. 2012 Dec;9(12):3270-3. doi: 10.1111/j.1743-6109.2012.02959.x. Epub 2012 Oct 22. ISSN: 1743-6095
• Single nucleotide polymorphisms in colorectal cancer: associations with tumor site and TNM stage. Mates IN, Jinga V, Csiki IE, Mates D, Dinu D, Constantin A, Jinga M. J Gastrointestin Liver Dis. 2012 Mar;21(1):45-52. ISSN: 1841-8724
• A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer. Gudmundsson J, Sulem P, Gudbjartsson DF, Masson G, Agnarsson BA, Benediktsdottir KR, Sigurdsson A, Magnusson OT, Gudjonsson SA, Magnusdottir DN, Johannsdottir H, Helgadottir HT, Stacey SN, Jonasdottir A, Olafsdottir SB, Thorleifsson G, Jonasson JG, Tryggvadottir L, Navarrete S, Fuertes F, Helfand BT, Hu Q, Csiki IE, Mates IN, Jinga V, Aben KK, van Oort IM, Vermeulen SH, Donovan JL, Hamdy FC, Ng CF, Chiu PK, Lau KM, Ng MC, Gulcher JR, Kong A, Catalona WJ, Mayordomo JI, Einarsson GV, Barkardottir RB, Jonsson E, Mates D, Neal DE, Kiemeney LA, Thorsteinsdottir U, Rafnar T, Stefansson K. Nat Genet. 2012 Dec;44(12):1326-9. doi: 10.1038/ng.2437. Epub 2012 Oct 28. ISSN: 1061-4036
• A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23. Wu X, Scelo G, Purdue MP, Rothman N, Johansson M, Ye Y, Wang Z, Zelenika D, Moore LE, Wood CG, Prokhortchouk E, Gaborieau V, Jacobs KB, Chow WH, Toro JR, Zaridze D, Lin J, Lubinski J, Trubicka J, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Jinga V, Bencko V, Slamova A, Holcatova I, Navratilova M, Janout V, Boffetta P, Colt JS, Davis FG, Schwartz KL, Banks RE, Selby PJ, Harnden P, Berg CD, Hsing AW, Grubb RL 3rd, Boeing H, Vineis P, Clavel-Chapelon F, Palli D, Tumino R, Krogh V, Panico S, Duell EJ, Quirós JR, Sanchez MJ, Navarro C, Ardanaz E, Dorronsoro M, Khaw KT, Allen NE, Bueno-de-Mesquita HB, Peeters PH, Trichopoulos D, Linseisen J, Ljungberg B, Overvad K, Tjønneland A, Romieu I, Riboli E, Stevens VL, Thun MJ, Diver WR, Gapstur SM, Pharoah PD, Easton DF, Albanes D, Virtamo J, Vatten L, Hveem K, Fletcher T, Koppova K, Cussenot O, Cancel-Tassin G, Benhamou S, Hildebrandt MA, Pu X, Foglio M, Lechner D, Hutchinson A, Yeager M, Fraumeni JF Jr, Lathrop M, Skryabin KG, McKay JD, Gu J, Brennan P, Chanock SJ. Hum Mol Genet. 2012 Jan 15;21(2):456-62. doi: 10.1093/hmg/ddr479. Epub 2011 Oct 18. ISSN: 0964-6906

2011

• A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Stacey SN, Sulem P, Jonasdottir A, Masson G, Gudmundsson J, Gudbjartsson DF, Magnusson OT, Gudjonsson SA, Sigurgeirsson B, Thorisdottir K, Ragnarsson R, Benediktsdottir KR, Nexø BA, Tjønneland A, Overvad K, Rudnai P, Gurzau E, Koppova K, Hemminki K, Corredera C, Fuentelsaz V, Grasa P, Navarrete S, Fuertes F, García-Prats MD, Sanambrosio E, Panadero A, Juan AD, Garcia A, Rivera F, Planelles D, Soriano V, Requena C, Aben KK, Rossum MM, Cremers RG, Oort IM, van Spronsen DJ, Schalken JA, Peters WH, Helfand BT, Donovan JL, Hamdy FC, Badescu D, Codreanu O, Jinga M, Csiki IE, Constantinescu V, Badea P, Mates IN, Dinu DE, Constantin A, Mates D, Kristjansdottir S, Agnarsson BA, Jonsson E, Barkardottir RB, Einarsson GV, Sigurdsson F, Moller PH, Stefansson T, Valdimarsson T, Johannsson OT, Sigurdsson H, Jonsson T, Jonasson JG, Tryggvadottir L, Rice T, Hansen HM, Xiao Y, Lachance DH, O Neill BP, Kosel ML, Decker PA, Thorleifsson G, Johannsdottir H, Helgadottir HT, Sigurdsson A, Steinthorsdottir V, Lindblom A; Swedish Low-risk Colorectal Cancer Study Group, Sandler RS, Keku TO, Banasik K, Jørgensen T, Witte DR, Hansen T, Pedersen O, Jinga V, Neal DE, Catalona WJ, Wrensch M, Wiencke J, Jenkins RB, Nagore E, Vogel U, Kiemeney LA, Kumar R, Mayordomo JI, Olafsson JH, Kong A, Thorsteinsdottir U, Rafnar T, Stefansson K. Nat Genet. 2011 Sep 25;43(11):1098-103. doi: 10.1038/ng.926. ISSN: 1061-4036
• Variant of TREM2 associated with the risk of Alzheimer's disease. T Jonsson, H Stefansson, S Steinberg, et al. – N Engl J Med 2013;368:107-116.
• Correlation between albuminemia, natremia and survival rates in patients with hepatorenal syndrome. Niculae A, Jinga M, Ciocâlteu A, Lascăr I, Jinga V, Checheriţă IA. Rom J Morphol Embryol. 2011;52(3):863-6. ISSN: 1220-0522
• Occupational exposure to arsenic, cadmium, chromium, lead and nickel, and renal cell carcinoma: a case-control study from Central and Eastern Europe. Boffetta P, Fontana L, Stewart P, Zaridze D, Szeszenia-Dabrowska N, Janout V, Bencko V, Foretova L, Jinga V, Matveev V, Kollarova H, Ferro G, Chow WH, Rothman N, van Bemmel D, Karami S, Brennan P, Moore LE. Occup Environ Med. 2011 Oct;68(10):723-8. ISSN: 1351-0711
• Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe. Chapple CR, Montorsi F, Tammela TL, Wirth M, Koldewijn E, Jinga V, Fernández Fernández E; European Silodosin Study Group. Eur Urol. 2011 Mar;59(3):342-52.
• Screening for Prostatic Tumors in Metabolic Syndrome Patients in Romania. Rusu F, Rusu E, Radulian G, Enache G, Jinga M, Rusu A, Jinga V, Codreanu O, Mischianu D, Cheta D. Acta Endo (Buc) 2011 (7): 47-58.

2010

• Genetic correction of PSA values using sequence variants associated with PSA levels. Gudmundsson J, Besenbacher S, Sulem P, Gudbjartsson DF, Olafsson I, Arinbjarnarson S, Agnarsson BA, Benediktsdottir KR, Isaksson HJ, Kostic JP, Gudjonsson SA, Stacey SN, Gylfason A, Sigurdsson A, Holm H, Bjornsdottir US, Eyjolfsson GI, Navarrete S, Fuertes F, Garcia-Prats MD, Polo E, Checherita IA, Jinga M, Badea P, Aben KK, Schalken JA, van Oort IM, Sweep FC, Helfand BT, Davis M, Donovan JL, Hamdy FC, Kristjansson K, Gulcher JR, Masson G, Kong A, Catalona WJ, Mayordomo JI, Geirsson G, Einarsson GV, Barkardottir RB, Jonsson E, Jinga V, Mates D, Kiemeney LA, Neal DE, Thorsteinsdottir U, Rafnar T, Stefansson K. Sci Transl Med. 2010 Dec 15;2(62):62ra92. doi: 10.1126/scitranslmed.3001513.